Clean Diesel Technologies, Inc. (CDTI) has licensed its patents for technologies for control of NOx emissions by selective catalytic reduction (SCR) to Robert Bosch GmbH on a worldwide, non-exclusive basis.
The patents Bosch has agreed to license include Clean Diesel’s ARIS (Advanced Reagent Injector System, earlier post) method of single-fluid return-flow cooled urea injection for SCR control of NOx emissions, as well as patents covering the combination of exhaust gas recirculation (EGR) with SCR to minimize toxic emissions while optimizing vehicle fuel efficiency.
In addition to providing cost-effective control of NOx emissions, the technologies support improved fuel economy. The agreement also includes provision for the use of these technologies in non-vehicular applications such as stationary power generation, rail and marine.
The terms were not disclosed, but Clean Diesel said that its licensing agreements generally are structured around license initiation fees and running royalty payments. Clean Diesel expects its 2007 financial results to include the first revenue under this agreement. Products incorporating these emission control and fuel-efficiency SCR technologies have been developed by Bosch.
This is a significant step for our Company. Clean Diesel has had prior agreements with major companies addressing retrofit markets, and this is the first license targeting a substantial portion of the new diesel vehicles with SCR technology that are predicted to be built over the next several years.—Bernhard Steiner, Clean Diesel Technologies CEO